These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 19789304)
21. Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus. Khavari A; Bolhassani A; Alizadeh F; Bathaie SZ; Balaram P; Agi E; Vahabpour R Arch Virol; 2015 Feb; 160(2):499-508. PubMed ID: 25395243 [TBL] [Abstract][Full Text] [Related]
22. A Genetically Modified attenuated Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878 [TBL] [Abstract][Full Text] [Related]
23. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635 [TBL] [Abstract][Full Text] [Related]
27. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model. Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination. Draghiciu O; Walczak M; Hoogeboom BN; Franken KL; Melief KJ; Nijman HW; Daemen T Int J Cancer; 2014 Feb; 134(4):859-72. PubMed ID: 23922012 [TBL] [Abstract][Full Text] [Related]
30. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297 [TBL] [Abstract][Full Text] [Related]
31. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Poo H; Pyo HM; Lee TY; Yoon SW; Lee JS; Kim CJ; Sung MH; Lee SH Int J Cancer; 2006 Oct; 119(7):1702-9. PubMed ID: 16646080 [TBL] [Abstract][Full Text] [Related]
32. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor. Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120 [TBL] [Abstract][Full Text] [Related]
33. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7. Chu NR; Wu HB; Wu T; Boux LJ; Siegel MI; Mizzen LA Clin Exp Immunol; 2000 Aug; 121(2):216-25. PubMed ID: 10931134 [TBL] [Abstract][Full Text] [Related]
34. A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers. Radaelli A; De Giuli Morghen C; Zanotto C; Pacchioni S; Bissa M; Franconi R; Massa S; Paolini F; Muller A; Venuti A Virus Res; 2012 Dec; 170(1-2):44-52. PubMed ID: 22951311 [TBL] [Abstract][Full Text] [Related]
35. Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors. Domingos-Pereira S; Galliverti G; Hanahan D; Nardelli-Haefliger D J Immunother Cancer; 2019 May; 7(1):122. PubMed ID: 31060612 [TBL] [Abstract][Full Text] [Related]
36. Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment. Song L; Yang MC; Knoff J; Wu TC; Hung CF PLoS One; 2014; 9(12):e115711. PubMed ID: 25531529 [TBL] [Abstract][Full Text] [Related]
37. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control. Lee IH; Park JB; Cheong M; Choi YS; Park D; Sin JI DNA Cell Biol; 2011 Dec; 30(12):975-85. PubMed ID: 21649506 [TBL] [Abstract][Full Text] [Related]
38. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein. Grasso F; Negri DR; Mochi S; Rossi A; Cesolini A; Giovannelli A; Chiantore MV; Leone P; Giorgi C; Cara A Int J Cancer; 2013 Jan; 132(2):335-44. PubMed ID: 22700466 [TBL] [Abstract][Full Text] [Related]
39. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70. Zhou L; Zhu T; Ye X; Yang L; Wang B; Liang X; Lu L; Tsao YP; Chen SL; Li J; Xiao X Hum Gene Ther; 2010 Jan; 21(1):109-19. PubMed ID: 19715402 [TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Kang TH; Lee JH; Song CK; Han HD; Shin BC; Pai SI; Hung CF; Trimble C; Lim JS; Kim TW; Wu TC Cancer Res; 2007 Jan; 67(2):802-11. PubMed ID: 17234792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]